Dr Tomasz Kamiński’s grant project was funded in Medical Research Agency’s call

23 05 2025

A research group led by Dr. Tomasz Kamiński from the Department of Molecular Biology at the Faculty of Biology, University of Warsaw, has received funds for the implementation of the project entitled “Development of a rapid and multiplex method for determining bacterial antimicrobial resistance using droplet microfluidics technology.” The funding was awarded as part of the Medical Research Agency’s call for scientific institutions to conduct application-oriented research in the biomedical field (2024/ABM/03/KPO).

The aim of the project is to develop a novel microfluidic technology for the rapid assessment of bacterial drug resistance. A key element of the project is to perform analyses in picoliter-volume droplets, in which bacteria will be encapsulated and cultured, with their growth monitored using highly sensitive microfluidic systems and ultra-fast optical measurements.

To reduce the time required to determine bacterial resistance, the team plans to optimize the microfluidic systems and apply machine learning methods for data analysis. The final version of the developed technology is expected to enable the simultaneous testing of various antibiotics on pathogenic bacteria, allowing for rapid and precise determination of minimum inhibitory concentrations (MIC).

The project also includes the acquisition of state-of-the-art equipment for fabricating microfluidic systems, which will be made available to the entire University of Warsaw community at the Ochota campus. Additionally, the project aims to train a broad group of researchers in the operation and application of this scientific equipment.

The project funding amounts to 4 277 614,61 PLN.

Photo. T. Kamiński